Stake Claim in an Expanding Market Niche
The ability to map an individual’s genomes has stirred a revolution in the medical field. In the field of oncology, being able to precisely identify a cancerous genome has allowed doctors to create therapies uniquely designed to target that specific genome. The cure for cancer—once a farfetched theory—is suddenly just around the corner.
N-of-One offers a highly valuable service, operating as a critical stage in the chain of testing and diagnosis processes. However, as science has advanced and the field has grown, their powerful offer was being drowned out by other companies that only offered small, isolated aspects of N-of-One’s diagnostic. CO OP created a brand that worked to help them define and own their unique sector, setting the groundwork for market leadership.